The effect of PRIME-MD on the detection and referral-for-treatment of occult psychiatric treatment in the Emergency Department (ED).
| ISRCTN | ISRCTN61514736 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN61514736 |
| Secondary identifying numbers | N/A |
- Submission date
- 17/02/2005
- Registration date
- 21/02/2005
- Last edited
- 03/08/2007
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr David Schriger
Scientific
Scientific
924 Westwood Blvd Suite 300
Los Angeles, CA
90024-2924
United States of America
| Phone | +1 310 794 0593 |
|---|---|
| schriger@ucla.edu |
Study information
| Study design | Randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Hospital |
| Study type | Diagnostic |
| Scientific title | |
| Study acronym | UCLA PRIME MD-2 |
| Study objectives | Not provided at time of registration. |
| Ethics approval(s) | Not provided at time of registration. |
| Health condition(s) or problem(s) studied | Depression, anxiety and other psychiatric conditions |
| Intervention | Patients take the computerized PRIME-MD in the ED waiting room. They are randomized to three groups: PRIME-MD results shared with no one, shared with the patient only, or shared with the patient and the treating ED physician. Low cost/no cost psychiatric referral sheet made available in the ED. |
| Intervention type | Other |
| Primary outcome measure | Not provided at time of registration. |
| Secondary outcome measures | Not provided at time of registration. |
| Overall study start date | 01/03/2002 |
| Completion date | 01/09/2002 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Not Specified |
| Target number of participants | Not provided at time of registration. |
| Key inclusion criteria | ED patients who present with a somatic (non-psychiatric) complaint that is of long duration, is chronic, or is not of a severity to warrant emergency care. Resident physicians in Emergency Medicine and their faculty. |
| Key exclusion criteria | Not provided at time of registration. |
| Date of first enrolment | 01/03/2002 |
| Date of final enrolment | 01/09/2002 |
Locations
Countries of recruitment
- United States of America
Study participating centre
924 Westwood Blvd Suite 300
Los Angeles, CA
90024-2924
United States of America
90024-2924
United States of America
Sponsor information
University of California, Los Angeles (UCLA) (USA)
University/education
University/education
924 Westwood Blvd Suite 300
Los Angeles, CA
90024 2924
United States of America
"ROR" |
https://ror.org/046rm7j60 |
|---|
Funders
Funder type
Industry
The Pfizer Corporation provided a $60,000 gift (not grant) in support of this research.
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | Results | 09/05/2005 | Yes | No |
